Epidemiology and clinical outcomes of light-chain amyloidosis in Sweden: A nationwide population-based study.

Ulf-Henrik MellqvistQian Cai Laura L HesterMichael GrövdalJakob BörsumIffat Rahman Eric M Ammann Markus Hansson

Published in: European journal of haematology (2023)

The incidence of newly diagnosed AL amyloidosis in Sweden increased over time with AL amyloidosis being associated with a higher risk of cardiac/renal failure and all-cause mortality compared with the general population.

Keyphrases

newly diagnosed
multiple myeloma
risk factors
left ventricular